Navigation Links
Simultaneous Applications Submitted to FDA and EMA for Siltuximab for the Treatment of Multicentric Castleman Disease, a Rare Blood Disorder
Date:9/3/2013

RARITAN, N.J., Sept. 3, 2013 /PRNewswire/ -- Janssen Research & Development, LLC ("Janssen") announced the simultaneous submissions of a Biologic License Application (BLA) to the United States Food and Drug Administration (U.S. FDA) and a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for siltuximab for the treatment of patients with multicentric Castleman disease (MCD) who are HIV-negative and human herpes virus-8 (HHV-8)-negative.

MCD is a rare disorder in which lymphocytes, a certain type of white blood cells, are over-produced and lead to enlargement of lymph nodes.1, 2 This can cause a variety of symptoms and weaken the immune system, making it hard to fight infection. Infections in people with MCD can be very serious and may even be fatal.3 Currently, there are no approved treatments in the U.S. or European Union (EU) for this rare blood disorder.

"We're proud of our work on siltuximab. As a rare disease with a small patient population, MCD is an area of significant unmet need," said Peter F. Lebowitz, M.D., Ph.D., global oncology therapeutic area head, Janssen. "Siltuximab works by targeting interleukin-6 which appears to be the critical driver of this disease. By focusing on core biologic mechanisms, we now have the potential of helping patients with a condition that is challenging to treat."  

Siltuximab has been granted orphan drug status in MCD in the U.S. and EU. The siltuximab regulatory submissions include data from a randomized, multi-national, double-blind, placebo-controlled study (MCD2001) and data from two non-randomized supportive studies. The MCD2001 study assessed the efficacy and safety of siltuximab plus best supportive care (BSC) compared with placebo plus BSC in patients with MCD.4 In the study, 79 patients were randomly assigned in a 2:1 ratio to one of the two treatment
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
2. Philips IMR offers new capabilities to simultaneously reduce CT Radiation and enhance image quality
3. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
4. Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications
5. Philips demonstrates innovations in nuclear medicine imaging with a comprehensive portfolio of NM applications for IntelliSpace Portal
6. Clinical Safety Data for ChromaDex®s Patented pTeroPure® (pterostilbene) Released at 6th World Congress on Polyphenols Applications in Paris
7. UltraTape announces Cleanroom Labels for Cryogenic Laboratory applications
8. New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of Life Science Applications
9. New Wireless Keyboard Rechargeable, Washable for Healthcare Applications
10. Frost & Sullivan: Label-Free Technology is a High Potential Market with Myriad Unexplored Applications
11. Radiotherapy Devices Market By Technology, Applications & Products (2011 - 2016)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015 International Isotopes Inc. (OTCQB: ... year ended December 31, 2014.  The Company reports a ... loss, and positive cash flow for the year ended ... in 2014 was approximately $7.5 million compared to approximately ... approximately 10%.  With the exception of the radiological services ...
(Date:4/1/2015)... 2015 LifeScienceIndustryResearch.com announces ... Industry and 2015 Deep Research Report on ... Pharmaceutical category in its database.  ... basic information, including definition, classification, application, industry ... news analysis, etc. Azithromycin Key Manufacturers Analysis ...
(Date:4/1/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Glucose Clamp Study. The study will be performed at ... San Antonio and University Health System,s ... Ralph DeFronzo . The glucose clamp is ...
Breaking Medicine Technology:International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3
... Reportlinker.com announces that a new market research report is available ... http://www.reportlinker.com/p0324750/Virtual-Pharma.html ... in the pharmaceutical market has slowed – almost to a ... cutting costs in a faltering world economy. ...
... NEW YORK, Nov. 3, 2010 Pfizer Inc. (NYSE: ... public to view and listen to a webcast of ... Primary Care, at the 2010 Annual Credit Suisse Healthcare ... Mountain Standard Time. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ...
Cached Medicine Technology:Reportlinker Adds Virtual Pharma 2Reportlinker Adds Virtual Pharma 3Reportlinker Adds Virtual Pharma 4Reportlinker Adds Virtual Pharma 5Reportlinker Adds Virtual Pharma 6
(Date:4/1/2015)... Franklin University, one of the leading ... establishment of the Greta J. Russell Medical Mutual of ... the generous gift of $100,000 from Medical Mutual of ... Medical Mutual to University representatives, Dr. David Decker ... & Strategic Relations. , “We are grateful to ...
(Date:4/1/2015)... ScooterDirect.com is a one stop online store that ... lifestyle using electric mobility scooters, power chairs and portable ... people, they provide mobility scooters at an affordable price. ... their freedom. Scooterdirect.com is offering Pride Go Go Traveller ... , One of the team members quoted, “Pride Go ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Amercanex Corporation, ... of the American Cannabis Exchange and will conduct its ... Native Roots joins the exchange as one of the ... licenses and operating fifteen stores in 9 locations with ... , “We are excited to have Native Roots ...
(Date:4/1/2015)... 2015 The dearth of qualified ... set to retire in the next five years) ... for laboratory automation. The application of advanced technology ... ensures timely progress and efficiency with minimal errors. ... automation in high-throughput screening, combinatorial chemistry, automated clinical ...
(Date:4/1/2015)... 2015 When you’re suffering from back pain, ... some relief. Identifying the causes of lingering back or neck ... the cause of chronic back pain is due to facet ... causes of back pain and offers many possible treatments, according ... of Atlantic Spine Center . , Dr. Liu clarifies ...
Breaking Medicine News(10 mins):Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 2Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 3Health News:ScooterDirect.com Offering Pride Go Go Traveller Elite 3 Wheel Scooter 2Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 2Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 3Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 2Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 3Health News:Demystifying Facet Joint Syndrome 2Health News:Demystifying Facet Joint Syndrome 3Health News:Demystifying Facet Joint Syndrome 4
... ... ... ... ...
... ... ... , , ... ...
... ... ... , , ... ...
... ... ... , ... , , ...
... for Medicare-eligible patients enrolled in clinical trials; however, only ... non-Medicare patients, and these offer less protection than the ... special article published online March 2 in the ... In the United States, participants, costs for routine ...
... well controlled and on low doses of inhaled corticosteroids, ... of three possible step-up treatments. National Jewish clinician-scientists Stanley ... Taussig, and colleagues in the NIH-funded Childhood Asthma Research ... online in the New England Journal of Medicine ...
Cached Medicine News:Health News:Nominate Your Hometown Hero to Serve as ExtenZe Racing's Honorary Crew Chief at a 2010 NASCAR Sprint Cup Race 2Health News:Nominate Your Hometown Hero to Serve as ExtenZe Racing's Honorary Crew Chief at a 2010 NASCAR Sprint Cup Race 3Health News:Nominate Your Hometown Hero to Serve as ExtenZe Racing's Honorary Crew Chief at a 2010 NASCAR Sprint Cup Race 4Health News:2010 Caring Coalition Conference Welcomes Author Gail Sheehy 2Health News:2010 Caring Coalition Conference Welcomes Author Gail Sheehy 3Health News:OrthoDynamix LLC Receives FDA 510(k) Clearance for ArthroSteer(R) 3.5mm Ablator 2Health News:OrthoDynamix LLC Receives FDA 510(k) Clearance for ArthroSteer(R) 3.5mm Ablator 3Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 60,800 Square Foot Medical Office Building in Mount Pleasant, South Carolina 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 60,800 Square Foot Medical Office Building in Mount Pleasant, South Carolina 3Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 60,800 Square Foot Medical Office Building in Mount Pleasant, South Carolina 4Health News:State payer mandates to cover cancer trials offer heterogeneous protection for patients 2Health News:Long-acting beta-agonists most effective step-up therapy for children with poorly controlled asthma 2
... The E-Holder™ Platform is designed with a ... 96 and E-Gel® 48 gel cassettes stay ... allows reproducible placement and loading from one ... make adjustments to the robot loading software. ...
... are seamless eliminating the possibility of leakage around ... have temperature resistant gel trays meaning you do ... For added user friendliness, the Primo tanks come ... The Primo Gel Systems are designed to ...
Designed for rapid, routine electrophoresis for nucleic acids. The Mini unit is designed with a choice of two casting systems: standard casting trays that require sealing tape; or aluminum-gated cast...
... horizontal gel system is designed for very fast and ... This System allows the user to cast, run, and ... system with : 1 x electrophoresis tank and cover, ... x 83 mm tray), 2 x MT-T02 (50 x ...
Medicine Products: